miércoles, 17 de diciembre de 2025
Applying Guideline-Directed Systemic Therapy for Advanced Bladder Cancer Dr Jose Tapia discusses guideline recommendations for systemic treatment in bladder cancer, and assesses therapeutic developments that will further shape guidance and improve outcomes Dr Jose Tapia
Applying Guideline-Directed Systemic Therapy for Advanced Bladder Cancer
Dr Jose Tapia discusses guideline recommendations for systemic treatment in bladder cancer, and assesses therapeutic developments that will further shape guidance and improve outcomes
Dr Jose Tapia
https://reference.medscape.com/cc1/p10/applying-guideline-directed-systemic-therapy-advanced-2025a1000lvm?ecd=WNL_drugguide_251217_MSCPREF_onc_etid7961611&uac=148436CN&impID=7961611
Top Tips: Metastatic Breast Cancer Dr Fharat Raja provides 10 top tips for oncologists on metastatic breast cancer, encompassing the latest UK, European, and US guidance Dr Fharat Raja
Top Tips: Metastatic Breast Cancer
Dr Fharat Raja provides 10 top tips for oncologists on metastatic breast cancer, encompassing the latest UK, European, and US guidance
Dr Fharat Raja
https://reference.medscape.com/cc1/p10/top-tips-metastatic-breast-cancer-2025a1000dc0?ecd=WNL_drugguide_251217_MSCPREF_onc_etid7961611&uac=148436CN&impID=7961611
Metastatic Malignant Disease of Unknown Primary Origin in Adults: Diagnosis and Management Source: National Institute for Health and Care Excellence
Metastatic Malignant Disease of Unknown Primary Origin in Adults: Diagnosis and Management
Source: National Institute for Health and Care Excellence
Cancer of Unknown Primary (NICE)
•Initial diagnostic steps
https://reference.medscape.com/cc2/p10/metastatic-malignant-disease-unknown-primary-origin-adults-2023a1000fgz?ecd=WNL_drugguide_251217_MSCPREF_onc_etid7961611&uac=148436CN&impID=7961611#1
•When to use PET–CT scans
https://reference.medscape.com/cc2/p10/metastatic-malignant-disease-unknown-primary-origin-adults-2023a1000fgz?ecd=WNL_drugguide_251217_MSCPREF_onc_etid7961611&uac=148436CN&impID=7961611#1
Bladder Cancer (ESMO) Source: European Society for Medical Oncology; Medically Reviewed by Professor Noel Clarke
Bladder Cancer (ESMO)
Bladder Cancer
Source: European Society for Medical Oncology; Medically Reviewed by Professor Noel Clarke
•Imaging and cytoscopy
https://reference.medscape.com/cc2/p10/guideline-essentials-2021-esmo-recommendations-bladder-2024a10003qf?ecd=WNL_drugguide_251217_MSCPREF_onc_etid7961611&uac=148436CN&impID=7961611
•Augmented visualization for TURBT
https://reference.medscape.com/cc2/p10/guideline-essentials-2021-esmo-recommendations-bladder-2024a10003qf?ecd=WNL_drugguide_251217_MSCPREF_onc_etid7961611&uac=148436CN&impID=7961611
•Neoadjuvant chemotherapy for MIBC
https://reference.medscape.com/cc2/p10/guideline-essentials-2021-esmo-recommendations-bladder-2024a10003qf?ecd=WNL_drugguide_251217_MSCPREF_onc_etid7961611&uac=148436CN&impID=7961611
Breast Cancer Germline Testing (ASCO) Source: American Society of Clinical Oncology, Society of Surgical Oncology; Medically Reviewed by Dr Fharat Raja
Breast Cancer Germline Testing (ASCO)
Germline Testing in Breast Cancer
Source: American Society of Clinical Oncology, Society of Surgical Oncology; Medically Reviewed by Dr Fharat Raja
In 2024, the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO) published a guideline on germline testing in breast cancer. This Medscape guideline summary covers BRCA1/2 testing for newly diagnosed patients, those with recurrent disease or second primaries, and those with personal history but no active disease, as well as the value of testing for other predisposition genes and genetic counselling. Please refer to the full ASCO–SSO guideline for all recommendations, rationale, and background information.
•When to offer BRCA1/2 testing
https://reference.medscape.com/cc2/p10/guideline-essentials-asco-sso-recommendations-germline-2025a10004h3?ecd=WNL_drugguide_251217_MSCPREF_onc_etid7961611&uac=148436CN&impID=7961611
•Testing for stage I–IV disease
https://reference.medscape.com/cc2/p10/guideline-essentials-asco-sso-recommendations-germline-2025a10004h3?ecd=WNL_drugguide_251217_MSCPREF_onc_etid7961611&uac=148436CN&impID=7961611
•Recurrent cancer and PARP inhibitors
https://reference.medscape.com/cc2/p10/guideline-essentials-asco-sso-recommendations-germline-2025a10004h3?ecd=WNL_drugguide_251217_MSCPREF_onc_etid7961611&uac=148436CN&impID=7961611
Palliative Care (ASCO) Source: American Society of Clinical Oncology; Medically Reviewed by Professor Graham Jackson
Palliative Care (ASCO)
Palliative Care Integration in Cancer Care
Source: American Society of Clinical Oncology; Medically Reviewed by Professor Graham Jackson
In 2024, the American Society of Clinical Oncology (ASCO) published an updated guideline on palliative care for patients with cancer. This Medscape guideline summary for oncologists provides recommendations regarding optimal provision of palliative care services for patients with cancer and their caregivers, updating previous ASCO guidance from 2012 and 2016. The update aims to equip oncology professionals with current recommendations while evaluating the continued validity of previous guidance, and includes new discussions on integrating palliative care for patients with haematological malignancies and those enrolled in phase I clinical trials, as well as addressing health equity in oncology palliative care.
•When to introduce palliative care
https://reference.medscape.com/cc2/p10/guideline-essentials-asco-recommendations-palliative-care-2025a1000kwr?ecd=WNL_drugguide_251217_MSCPREF_onc_etid7961611&uac=148436CN&impID=7961611
•Referral for poor-prognosis cancers
https://reference.medscape.com/cc2/p10/guideline-essentials-asco-recommendations-palliative-care-2025a1000kwr?ecd=WNL_drugguide_251217_MSCPREF_onc_etid7961611&uac=148436CN&impID=7961611
•Supporting caregiver needs
https://reference.medscape.com/cc2/p10/guideline-essentials-asco-recommendations-palliative-care-2025a1000kwr?ecd=WNL_drugguide_251217_MSCPREF_onc_etid7961611&uac=148436CN&impID=7961611
Suscribirse a:
Comentarios (Atom)

